Results for tag: "Acivicin"

The Acivicin market is a subset of the Oncology Drugs market, which focuses on treatments for cancer. Acivicin is a chemotherapy drug used to treat a variety of cancers, including colorectal, ovarian, and non-small cell lung cancer. It is administered intravenously and works by inhibiting the growth of cancer cells. Acivicin is often used in combination with other drugs to maximize its effectiveness. The Acivicin market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca. Other companies, such as Novartis, Sanofi, and GlaxoSmithKline, also offer Acivicin-based treatments. Show Less Read more